isatin has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdel-Meguid, SS; Adams, JL; Badger, AM; Chan, G; Chan, W; Concha, NO; Debouck, C; DeWolf, WE; Francis, TA; Gowen, M; Haltiwanger, RC; Head, MS; Janson, CA; Johanson, K; Keller, PM; Kikly, K; Lark, MW; Lee, D; Levy, MA; Liang, PH; Long, SA; McDevitt, PJ; Nadeau, DP; Nuttall, ME; Richardson, S; Ryan, MD; Sung, CM; Suva, LJ; Tomaszek, T; Vaidya, KS; Winkler, JD | 1 |
Beckius, GE; Chapman, JG; Magee, WP; Milici, AJ; Stukenbrok, HA; Tracey, WR | 1 |
2 other study(ies) available for isatin and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
Article | Year |
---|---|
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Binding Sites; Camptothecin; Caspase 3; Caspase 7; Caspase Inhibitors; Chondrocytes; Collagen; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Isatin; Mice; Models, Molecular; Molecular Structure; Neutrophils; Osteoarthritis; Promoter Regions, Genetic; Recombinant Proteins; Sulfonamides | 2000 |
A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Caspase 3; Caspase 7; Caspase Inhibitors; Caspases; Cell Line; Cells, Cultured; Coronary Circulation; Cysteine Proteinase Inhibitors; Dipeptides; Dose-Response Relationship, Drug; Heart Rate; In Situ Nick-End Labeling; Isatin; Ketones; Male; Microscopy, Electron; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Pyrrolidines; Rabbits | 2002 |